Gilbert Marks
Direktor/Vorstandsmitglied bei AN2 THERAPEUTICS, INC.
Vermögen: 45 432 $ am 31.05.2024
Aktive Positionen von Gilbert Marks
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AN2 THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.02.2020 | - |
Independent Dir/Board Member | 01.02.2020 | - | |
Biomedical Advanced Research & Development Authority | Corporate Officer/Principal | - | - |
Karriereverlauf von Gilbert Marks
Ehemalige bekannte Positionen von Gilbert Marks
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tunnell Government Services, Inc.
Tunnell Government Services, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Government Services, Inc. provides assistance for government agencies. It Offer Services in public health preparedness and response, bioscience lab services, and scientific project portfolio management. The company was founded in June 2008 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01.09.2017 | 01.09.2021 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | 01.01.2020 | 01.09.2021 |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 01.01.2016 | 01.01.2021 |
Women Organized Against Rape | Direktor/Vorstandsmitglied | 01.01.2017 | 01.01.2021 |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Vorsitzender | 01.01.2006 | 01.01.2018 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1993 | 01.01.2017 |
Ausbildung von Gilbert Marks
Auburn University | Undergraduate Degree |
University of South Alabama | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AN2 THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Tunnell Government Services, Inc.
Tunnell Government Services, Inc. Miscellaneous Commercial ServicesCommercial Services Tunnell Government Services, Inc. provides assistance for government agencies. It Offer Services in public health preparedness and response, bioscience lab services, and scientific project portfolio management. The company was founded in June 2008 and is headquartered in Bethesda, MD. | Commercial Services |
Biomedical Advanced Research & Development Authority | |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National Center for Advancing Translational Sciences studies translation on a system-wide level as a scientific and operational problem. The company was founded in 2012 and is headquartered in Rockville, MD. | Government |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Women Organized Against Rape |
- Börse
- Insiders
- Gilbert Marks
- Erfahrung